Isolated ACTH Deficiency in Patients With Hashimoto Thyroiditis

This study has been completed.

Sponsor:

Information provided by:

University of Wuerzburg

ClinicalTrials.gov Identifier:

NCT00552487

First received: October 31, 2007

Last updated: NA

Last verified: October 2007

History: No changes posted

Purpose

The purpose of this study is to determine whether patients with Hashimoto thyroiditis and impaired well-being may have a partial secondary adrenocortical insufficiency.

Condition	Intervention
Hashimoto Disease Adrenal Insufficiency	Drug: synacthen


Study Type:	Interventional
Study Design:	Intervention Model: Parallel Assignment Masking: None (Open Label) Primary Purpose: Diagnostic
Official Title:	Isolated ACTH Deficiency in Patients With Hashimoto Thyroiditis

Resource links provided by NLM:

Genetics Home Reference related topics: Hashimoto thyroiditis familial glucocorticoid deficiency

Genetic and Rare Diseases Information Center resources: Lymphomatous Thyroiditis Hypoadrenalism Isolated ACTH Deficiency

U.S. FDA Resources

Further study details as provided by University of Wuerzburg:

Primary Outcome Measures:

serum cortisol-peak 30 min after ACTH-stimulation [ Time Frame: 30 minutes ]

Secondary Outcome Measures:

serum DHEA-peak 30 min. after ACTH-stimulation,DHEA-S, ACTH [ Time Frame: 30 minutes ]


Enrollment:	62
Study Start Date:	October 2005
Study Completion Date:	July 2006

Arms	Assigned Interventions
1 healthy people without Hashimoto disease receive a 1µg ACTH stimulation test	Drug: synacthen 1 µg synacthen in the vein Other Name: ACTH
2 patients with Hashimoto disease with well being receive a 1 µg ACTH stimulation test	Drug: synacthen 1 µg synacthen in the vein Other Name: ACTH
3 patients with Hashimoto disease an impaired well-being receive a 1 µg ACTH stimulation test	Drug: synacthen 1 µg synacthen in the vein Other Name: ACTH
4 patients with Hashimoto disease and negative TPO antibodies receive a 1µg ACTH stimulation test	Drug: synacthen 1 µg synacthen in the vein Other Name: ACTH

Detailed Description:

Many patients with Hashimoto thyroiditis who are correctly substituted with thyroid hormones have an impaired well-being. in some people an isolated ACTH deficiency was found.

In this study a 1 µg ACTH test is performed to evaluate the adrenocortical function.

Eligibility


Ages Eligible for Study:	18 Years and older (Adult, Senior)
Sexes Eligible for Study:	All
Accepts Healthy Volunteers:	Yes

Criteria

Inclusion Criteria:

Hashimoto thyroiditis euthyreot thyroid function with levothyroxin therapy written informed consent

Exclusion Criteria:

• hypothyroidism of other origin
- pregnancy and lactation
- oral contraception
- glucocorticoid therapy during the last 2 months
- History of malignancy or chronic infections (Hepatitis, HIV)

Contacts and Locations

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00552487

Locations


Germany
University of Wuerzburg, Department of Endocrinology
Wuerzburg, Bavaria, Germany, 97080

Sponsors and Collaborators

University of Wuerzburg

Investigators


Principal Investigator:	Bruno Allolio, MD	University of Wuerzburg

More Information


ClinicalTrials.gov Identifier:	NCT00552487 History of Changes
Other Study ID Numbers:	112/05
Study First Received:	October 31, 2007
Last Updated:	October 31, 2007

Keywords provided by University of Wuerzburg:


isolated ACTH deficiency Hashimoto disease Hashimoto thyroiditis autoimmune thyroiditis

Additional relevant MeSH terms:


Adrenal Insufficiency Thyroiditis Hashimoto Disease Endocrine System Diseases Hypoglycemia Genetic Diseases, Inborn Adrenal Gland Diseases Thyroid Diseases	Thyroiditis, Autoimmune Glucose Metabolism Disorders Metabolic Diseases Adrenocorticotropic Hormone Hormones Hormones, Hormone Substitutes, and Hormone Antagonists Physiological Effects of Drugs

ClinicalTrials.gov processed this record on September 21, 2017

To Top